NeoGenomics Announces Results for the 3rd Quarter 2007
...illion in Q3 07 from $880,000 in Q3 '06. We
experienced some compression in our gross margin percentage on a
year-over-year basis, because the popular pathvysion
breast cancer FISH
test is only a two probe test which has relatively high supply costs and
significantly lower average reimbursement than other FISH ...
PathVysion in Medical Technology
PathVysion in Medical Products
PathVysion® HER-2 DNA Probe Kit
is the only HER-2 assessment test approved by the U.S Food and Drug Adminis...ion and Herceptin® (Trastuzumab) monoclonal antibody therapy selection. pathvysion
is the only FISH-based DNA probe HER-2 test listed in the Herceptin® pa...